BrainsWay (BWAY) to Advance in DEEP TMS for MDD With New Trial

BrainsWay Ltd. (BWAY) , a prominent player in noninvasive neurostimulation treatments, has initiated a clinical trial aimed at evaluating a new accelerated treatment protocol for its Deep Transcranial Magnetic Stimulation (Deep TMS) system in treating major depressive disorder (MDD). This prospective, randomized, controlled, multicenter trial represents a significant step forward in mental health treatment, particularly for those suffering from MDD. The initiation of this clinical trial underscores BrainsWa ...